The DOI matches its Crossref record; 3 of the 3 references it cites were found in a registry or an index.
DOPAL derived alpha-synuclein oligomers impair synaptic vesicles physiological function
Abstract
Parkinson’s disease is a neurodegenerative disorder characterized by the death of dopaminergic neurons and by accumulation of alpha-synuclein (aS) aggregates in the surviving neurons. The dopamine catabolite 3,4-dihydroxyphenylacetaldehyde (DOPAL) is a highly reactive and toxic molecule that leads to aS oligomerization by covalent modifications to lysine residues. Here we show that DOPAL-induced aS oligomer formation in neurons is associated with damage of synaptic vesicles, and with alterations in the synaptic vesicles pools. To investigate the molecular mechanism that leads to synaptic impairment, we first aimed to characterize the biochemical and biophysical properties of the aS-DOPAL oligomers; heterogeneous ensembles of macromolecules able to permeabilise cholesterol-containing lipid membranes. aS-DOPAL oligomers can induce dopamine leak in an in vitro model of synaptic vesicles and in cellular models. The dopamine released, after conversion to DOPAL in the cytoplasm, could trigger a noxious cycle that further fuels the formation of aS-DOPAL oligomers, inducing neurodegeneration.
Overview
The claims and statistics of this paper haven’t been checked yet.
Run the check — free, no account needed. It reads the open-access text and checks the sources it cites.
Integrity signals
Registry
Cites
Statistics
Verification
Claims the paper makes
The claims and statistics of this paper haven’t been checked yet.
Run the check — free, no account needed. It reads the open-access text and checks the sources it cites.
Self-check
Percentages, sums and reported differences re-computed from the paper’s own numbers.
The self-check needs the paper’s full text.
Citations
Cites
Molecular anatomy of a trafficking organelle
Takamori, S., Holt, M., Stenius, K., Lemke, E. A., Grønborg, M., Riedel, D., Urlaub, H., Schenck, S., Brügger, B., Ringler, P., et al. (2006) · Cell · doi:10.1016/j.cell.2006.10.030 · Cited by 2,373
Mice Lacking α-Synuclein Display Functional Deficits in the Nigrostriatal Dopamine System
Abeliovich, A., Schmitz, Y., Fariñas, I., Choi-Lundberg, D., Ho, W.-H., Castillo, P. E., Shinsky, N., Verdugo, J. M. G., Armanini, M., Ryan, A., et al. (2000) · Neuron · doi:10.1016/s0896-6273(00)80886-7 · Cited by 1,722
Aldehyde dehydrogenase 1 defines and protects a nigrostriatal dopaminergic neuron subpopulation
Liu, G., Yu, J., Ding, J., Xie, C., Sun, L., Rudenko, I., Zheng, W., Sastry, N., Luo, J., Rudow, G., et al. (2014) · Journal of Clinical Investigation · doi:10.1172/jci72176 · Cited by 166
Research works printed but not linked: 49
- German, D. C., Manaye, K., Smith, W. K., Woodward, D. J. & Saper, C. B. Midbrain dopaminergic cell loss in Parkinson’s disease: computer visualization. Ann Neurol 26, 507–514 (1989). · DOI · Paper page
- Bisaglia, M., Greggio, E., Beltramini, M. & Bubacco, L. Dysfunction of dopamine homeostasis: Clues in the hunt for novel Parkinson’s disease therapies. FASEB J 27, 2101–2110 (2013). · DOI
- Goldstein, D. S., Kopin, I. J. & Sharabi, Y. Catecholamine autotoxicity. Implications for pharmacology and therapeutics of Parkinson disease and related disorders. Pharmacol Ther 1110 (2014). · DOI · Paper page
- Galvin, J. E. Interaction of alpha-synuclein and dopamine metabolites in the pathogenesis of Parkinson’s disease: a case for the selective vulnerability of the substantia nigra. Acta Neuropathol 112, 115–126 (2006). · DOI
- Goldstein, D. S. et al. Determinants of buildup of the toxic dopamine metabolite DOPAL in Parkinson’s disease. J Neurochem 126, 591–603 (2013). · DOI · Paper page
- Goldstein, D. S. et al. Catechols in post-mortem brain of patients with Parkinson disease. Eur J Neurol 18, 703–710 (2011). · DOI
- Grünblatt, E. et al. Gene expression profiling of parkinsonian substantia nigra pars compacta; alterations in ubiquitin-proteasome, heat shock protein, iron and oxidative stress regulated proteins, cell adhesion/cellular matrix and vesicle trafficking genes. J Neural Transm 111, 1543–1573 (2004). · DOI · Paper page
- Doorn, J. a., Florang, V. R., Schamp, J. H. & Vanle, B. C. Aldehyde dehydrogenase inhibition generates a reactive dopamine metabolite autotoxic to dopamine neurons. Park Relat Disord 20, S73–S75 (2014). · DOI
- Fitzmaurice, A. G. et al. Aldehyde dehydrogenase inhibition as a pathogenic mechanism in Parkinson disease. Proc Natl Acad Sci USA 110, 636–41 (2013). · DOI · Paper page
- Fitzmaurice, A. G., Rhodes, S. L., Cockburn, M., Ritz, B. & Bronstein, J. M. Aldehyde dehydrogenase variation enhances effect of pesticides associated with Parkinson disease. Neurology 82, 419–426 (2014). · DOI
- Legros, H., Dingeval, M. G., Janin, F., Costentin, J. & Bonnet, J. J. Toxicity of a treatment associating dopamine and disulfiram for catecholaminergic neuroblastoma SH-SY5Y cells: Relationships with 3,4-dihydroxyphenylacetaldehyde formation. Neurotoxicology 25, 365–375 (2004). · doi:10.1016/s0161-813x(03)00148-7
- Wey, M. C. Y. et al. Neurodegeneration and motor dysfunction in mice lacking cytosolic and mitochondrial aldehyde dehydrogenases: Implications for parkinson’s disease. PLoS One 7 (2012). · DOI · Paper page
- Spillantini, M. G. et al. Alpha-synuclein in Lewy bodies. Nature 388, 839–840 (1997). · DOI · Paper page
- Kasten, M. & Klein, C. The many faces of alpha-synuclein mutations. Mov Disord 28, 697–701 (2013). · DOI
- Nemani, V. M. et al. Article Increased Expression of a -Synuclein Reduces Neurotransmitter Release by Inhibiting Synaptic Vesicle Reclustering after Endocytosis. Neuron 65, 66–79 (2010). · DOI · Paper page
- Scott, D. & Roy, S. -Synuclein Inhibits Intersynaptic Vesicle Mobility and Maintains Recycling-Pool Homeostasis. J Neurosci 32, 10129–10135 (2012). · DOI · Paper page
- Burré, J. et al. Alpha-synuclein promotes SNARE-complex assembly in vivo and in vitro . Science 329, 1663–1667 (2010). · DOI · Paper page
- Outeiro, T. F. et al. Dopamine-Induced Conformational Changes in Alpha- Synuclein. PLoS One 4, 1–11 (2009). · DOI
- Nakamura, K. Alpha-Synuclein and Mitochondria: Partners in Crime? Neurotherapeutics 10, 391–399 (2013). · DOI
- Ebrahimi-Fakhari, D., Wahlster, L. & McLean, P. J. Protein degradation pathways in Parkinson’s disease: Curse or blessing. Acta Neuropathol 124, 153–172 (2012). · DOI · Paper page
- Auluck, P. K., Caraveo, G. & Lindquist, S. α-Synuclein: membrane interactions and toxicity in Parkinson’s disease. Annu Rev Cell Dev Biol 26, 211–233 (2010). · DOI · Paper page
- Plotegher, N., Greggio, E., Bisaglia, M. & Bubacco, L. Biophysical groundwork as a hinge to unravel the biology of α-synuclein aggregation and toxicity. Q Rev Biophys 1, 1–48 (2014). · DOI
- Wilhelm, B. G. et al. Composition of isolated synaptic boutons reveals the amounts of vesicle trafficking proteins. Science (80-) 344, 1023–1028 (2014). · DOI · Paper page
- Theillet, F.-X. et al. Structural disorder of monomeric α-synuclein persists in mammalian cells. Nature 530, 45–50 (2016). · DOI · Paper page
- Plotegher, N. & Bubacco, L. Lysines, Achilles’ heel in alpha-synuclein conversion to a deadly neuronal endotoxin. Ageing Res Rev 26, 62–71 (2016). · DOI
- Burke, W. J. et al. Aggregation of α-synuclein by DOPAL, the monoamine oxidase metabolite of dopamine. Acta Neuropathol 115, 193–203 (2008). · DOI · Paper page
- Goldstein, D. S. et al. Vesicular uptake blockade generates the toxic dopamine metabolite 3,4-dihydroxyphenylacetaldehyde in PC12 cells: Relevance to the pathogenesis of Parkinson’s disease. J Neurochem 123, 932–943 (2012). · DOI
- Jinsmaa, Y. et al. Divalent metal ions enhance DOPAL-induced oligomerization of alpha-synuclein. Neurosci Lett 569, 27–32 (2014). · DOI
- Follmer, C. et al. Oligomerization and Membrane-Binding Properties of Covalent Adducts Formed by the Interaction of Alpha-Synuclein with the Toxic Dopamine Metabolite 3,4-Dihydroxyphenylacetaldehyde (DOPAL). J Biol Chem 290, jbc.M115.686584 (2015). · DOI · Paper page
- Daniele, F., Di Cairano, E. S., Moretti, S., Piccoli, G. & Perego, C. TIRFM and pH-sensitive GFP-probes to Evaluate Neurotransmitter Vesicle Dynamics in SH-SY5Y Neuroblastoma Cells: Cell Imaging and Data Analysis. J Vis Exp e52267, doi: 10.3791/52267 (2015). · doi:10.3791/52267
- Belluzzi, E. et al. LRRK2 phosphorylates pre-synaptic N-ethylmaleimide sensitive fusion (NSF) protein enhancing its ATPase activity and SNARE complex disassembling rate. Mol Neurodegener 11, 1 (2016). · DOI · Paper page
- Piccoli, G. et al. LRRK2 Controls Synaptic Vesicle Storage and Mobilization within the Recycling Pool. J Neurosci 31, 2225–2237 (2011). · DOI · Paper page
- Rees, J. N., Florang, V. R., Eckert, L. L. & Doorn, J. a. Protein reactivity of 3,4-dihydroxyphenylacetaldehyde, a toxic dopamine metabolite, is dependent on both the aldehyde and the catechol. Chem Res Toxicol 22, 1256–1263 (2009). · DOI
- Lashuel, H. a. et al. Α-Synuclein, Especially the Parkinson’S Disease-Associated Mutants, Forms Pore-Like Annular and Tubular Protofibrils. J Mol Biol 322, 1089–1102 (2002). · DOI · Paper page
- Kim, H.-Y. et al. Structural Properties of Pore-Forming Oligomers of alpha -Synuclein. J- Amer Chem Soc 131, 17482–17489 (2009). · DOI · Paper page
- Quist, A. et al. Amyloid ion channels: a common structural link for protein-misfolding disease. Proc Natl Acad Sci USA 102, 10427–10432 (2005). · DOI · Paper page
- Chen, S. W. et al. Structural characterization of toxic oligomers that are kinetically trapped during α-synuclein fibril formation. Proc Natl Acad Sci USA 112, E1994–2003 (2015).
- Plotegher, N. et al. The chaperone-like protein 14-3-3η interacts with human α-synuclein aggregation intermediates rerouting the amyloidogenic pathway and reducing α-synuclein cellular toxicity. Hum Mol Genet 1–38, doi: 10.1093/hmg/ddu275 (2014). · DOI
- Stöckl, M. T., Zijlstra, N. & Subramaniam, V. α-Synuclein Oligomers: an Amyloid Pore? - Insights into Mechanisms of α-Synuclein Oligomer-Lipid Interactions. Mol Neurobiol 1–9, doi: 10.1007/s12035-012-8331-4 (2012). · DOI
- Tosatto, L. et al. Alpha-synuclein pore forming activity upon membrane association. Biochim Biophys Acta - Biomembr 1818, 2876–2883 (2012). · DOI
- De Franceschi, G. et al. Structural and morphological characterization of aggregated species of α-synuclein induced by docosahexaenoic acid. J Biol Chem 286, 22262–22274 (2011). · DOI
- Van Maarschalkerweerd, A., Vetri, V. & Vestergaard, B. Cholesterol facilitates interactions between α-synuclein oligomers and charge-neutral membranes. FEBS Lett 589, 2661–2667 (2015). · DOI
- Jao, C. C., Der-Sarkissian, A., Chen, J. & Langen, R. Structure of membrane-bound α-synuclein studied by site-directed spin labeling. Proc Natl Acad Sci USA 101, 8331–8336 (2004). · DOI · Paper page
- Jao, C. C., Hegde, B. G., Chen, J., Haworth, I. S. & Langen, R. Structure of membrane-bound alpha-synuclein from site-directed spin labeling and computational refinement. Proc Natl Acad Sci USA 105, 19666–19671 (2008). · DOI · Paper page
- Tessari, I. et al. The reaction of α-synuclein with tyrosinase: Possible implications for parkinson disease. J Biol Chem 283, 16808–16817 (2008). · DOI
- Robbins, J. H. Preparation and Properties of p-Hydroxyphenylacetaldehyde and 3-Methoxy-4-Hydroxyphenylacetaldehyde. Arch Biochem Biophys 114, 576–584 (1966). · doi:10.1016/0003-9861(66)90382-1
- Dalla Serra, M. & Menestrina, G. Characterization of molecular properties of pore-forming toxins with planar lipid bilayers. Methods Mol Biol 145, 171–88 (2000).
- Czajkowsky, D. M., Hotze, E. M., Shao, Z. & Tweten, R. K. Vertical collapse of a cytolysin prepore moves its transmembrane beta-hairpins to the membrane. EMBO J 23, 3206–15 (2004). · doi:10.1038/sj.emboj.7600350
- Nikonenko, A. G. & Skibo, G. G. Technique to quantify local clustering of synaptic vesicles using single section data. Microsc Res Tech 65, 287–291 (2004). · DOI
Cited by
13 reasons why the brain is susceptible to oxidative stress
Cobley, J. N., Fiorello, M. L., & Bailey, D. M. (2018) · Redox Biology · doi:10.1016/j.redox.2018.01.008 · Cited by 1,215
Oxidative stress and cellular pathologies in Parkinson’s disease
Puspita, L., Chung, S. Y., & Shim, J.-W. (2017) · Molecular Brain · doi:10.1186/s13041-017-0340-9 · Cited by 483
Alpha-synuclein oligomers: a new hope
Bengoa-Vergniory, N., Roberts, R. F., Wade-Martins, R., & Alegre-Abarrategui, J. (2017) · Acta Neuropathologica · doi:10.1007/s00401-017-1755-1 · Cited by 338
Synaptic, Mitochondrial, and Lysosomal Dysfunction in Parkinson’s Disease
Nguyen, M., Wong, Y. C., Ysselstein, D., Severino, A., & Krainc, D. (2019) · Trends in Neurosciences · doi:10.1016/j.tins.2018.11.001 · Cited by 323
Impaired dopamine metabolism in Parkinson’s disease pathogenesis
Masato, A., Plotegher, N., Boassa, D., & Bubacco, L. (2019) · Molecular Neurodegeneration · doi:10.1186/s13024-019-0332-6 · Cited by 328
Self-citation
Metadata
- Authors
- Plotegher, N., Berti, G., Ferrari, E., Tessari, I., Zanetti, M., Lunelli, L., Greggio, E., Bisaglia, M., Veronesi, M., Girotto, S., Dalla Serra, M., Perego, C., Casella, L., & Bubacco, L.
- Venue
- Scientific Reports
- Published
- 2017-01-13
- Volume
- 7
- Issue
- 1
- ISSN
- 2045-2322
- Cited by
- 133
- References
- 3
- Language
- en
- Licence
- creativecommons.org/licenses/by/4.0 (tdm)
- creativecommons.org/licenses/by/4.0 (vor)
About these checks
Registry, retraction, Cites and statistics results are computed, not judged, with one exception: a printed reference that no index lists is read once by a model before it counts as a citation error. Claims are extracted by a model and kept only when their quote appears verbatim in the text; each cited source is then checked, with a model’s help, for whether it says what the claim relies on. Those verdicts can be wrong — read the claim’s quote and the cited source before relying on one.
Statistics and arithmetic are recomputed, not judged.
Confidence bands are shown only for fields calibrated on our annotated test set. None is calibrated yet, so no band is shown.
What counts as a claim ›How we measure confidence ›How we check this ›
Are you an author, or do you see a problem with this page? Request a review
Data sources
Bibliographic data: Semantic Scholar, OpenAlex, Crossref.
Contains information from the Semantic Scholar Academic Graph Datasets, made available under the ODC Attribution License (ODC-BY 1.0).
Semantic Scholar’s data is described in: Kinney, R., et al. (2023). The Semantic Scholar Open Data Platform. arXiv:2301.10140.